K980631

Substantially Equivalent

EMBOL-X AORTIC OCCLUSION AND CARDIOPLEGIA CANNULA

Applicant: Embol-X, Inc.
Product code: DXC
Advisory panel: Cardiovascular
Date received: 1998-02-18
Decision date: 1999-02-02
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mountain View, CA, US

Adverse events under product code DXC

product code DXC

Death: 14
Injury: 442
Malfunction: 2,209
Other: 1
Total: 2,666

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.